Publications
Publications 3001 - 3025 de 33557
| Titre | DOI |
|---|---|
|
ANTI TNF TREATMENT OF REACTIVE ARTHRITIS - A MONOCENTRIC EXPERIENCE A. Brinster; X. Guillot; C. Prati; D. Wendling 2016 |
|
|
ANTI TNF TREATMENT OF REACTIVE ARTHRITIS. A MONOCENTRIC EXPERIENCE A. Brinster; X. Guillot; C. Prati; D. Wendling 2016 |
10.1136/annrheumdis-2016-eular.1700 |
|
Anti-Aging Effects of GDF11 on Skin L. Rochette; L. Mazini; A. Meloux; M. Zeller; Y. Cottin; C. Vergely; G. Malka 2020 |
10.3390/ijms21072598 |
|
Anti-angiogenic treatments in metastatic colorectal cancer: Does a continuous angiogenic blockade make sense? M. Jary; C. Borg; O. Bouche; S. Kim; T. Andre; J. Bennouna 2015 |
10.1016/j.bulcan.2015.05.002 |
|
Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease A. Floch; A. Morel; F. Zanchetta-Balint; C. Cordonnier-Jourdin; S. Allali; M. Grall; G. Ithier; B. Carpentier; S. Pakdaman; J.C. Merle; R. Goulabchand; T. Khalifeh; A. Berceanu; C. Helmer; C. Chantalat-Auger; V. Fremeaux-Bacchi; M. Michel; M. de Montalembert; A. Mekontso-Dessap; F. Pirenne; A. Habibi; P. Bartolucci 2020 |
10.3324/haematol.2020.253856 |
|
Anti-Cancer Activity of Resveratrol and Derivatives Produced by Grapevine Cell Suspensions in a 14 L Stirred Bioreactor L. Nivelle; J. Hubert; E. Courot; P. Jeandet; A. Aziz; J.M. Nuzillard; J.H. Renault; C. Clement; L. Martiny; D. Delmas; M. Tarpin 2017 |
10.3390/molecules22030474 |
|
Anti-Congestion Algorithm for Multiple Data Unicast Transmission in the Internet of Brain Things X. Yan; W. Yan; L. Zhang 2018 |
10.1109/ACCESS.2018.2883684 |
|
Anti-diabetic and lipid-lowering effects of drimane sesquiterpenoids isolated from Zygogynum pancheri S. Belhadj; H. Keskes; C. Apel; F. Roussi; M. Litaudon; O. Hentati; N. Allouche 2020 |
10.1016/j.cbi.2020.109167 |
|
Anti-Domain I beta(2)-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study S. Zuily; B. de Laat; F. Guillemin; H. Kelchtermans; N. Magy-Bertrand; H. Desmurs-Clavel; M. Lambert; V. Poindron; E. De Maistre; V. Dufrost; J. Risse; Z. Shums; G.L. Norman; P.G. de Groot; P. Lacolley; T. Lecompte; V. Regnault; D. Wahl; T.A.C.I.T.Study Grp 2020 |
10.1093/jalm/jfaa072 |
|
ANTI-DONOR HLA ANTIBODY RESPONSE AFTER PANCREATIC ISLET GRAFTING: CHARACTERISTICS, RISK FACTORS AND IMPACT ON GRAFT FUNCTION E. Pouliquen; P. Baltzinger; A. Lemle; C. Chen; A. Parissiadis; S. Borot; L. Frimat; S. Girerd; T. Berney; S. Lablanche; P.Y. Benhamou; E. Morelon; L. Badet; V. Dubois; L. Kessler; O. Thaunat 2017 |
|
|
ANTI-DONOR HLA ANTIBODY RESPONSE AFTER PANCREATIC ISLET GRAFTING: CHARACTERISTICS, RISK FACTORS AND IMPACT ON GRAFT FUNCTION E. Pouliquen; P. Baltzinger; A. Lemle; C. Chen; A. Parissiadis; S. Borot; L. Frimat; S. Girerd; T. Berney; S. Lablanche; P.Y. Benhamou; E. Morelon; L. Badet; V. Dubois; L. Kessler; O. Thaunat 2017 |
|
|
Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function E. Pouliquen; P. Baltzinger; A. Lemle; C.C. Chen; A. Parissiadis; S. Borot; L. Frimat; S. Girerd; T. Berney; S. Lablanche; P.Y. Benhamou; E. Morelon; L. Badet; V. Dubois; L. Kessler; O. Thaunat; G.R.A.G.I.L. Network 2017 |
10.1111/ajt.13936 |
|
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904) V. Vendrely; C. Lemanski; K. Gnep; E. Barbier; F.El Hajbi; G. Lledo; L. Dahan; E. Terrebonne; S. Manfredi; X. Mirabel; V. Mammar; D. Cowen; C. Lepage; T. Aparicio; F.F.C.D.Investigat Collaborators 2019 |
10.1016/j.radonc.2019.05.018 |
|
Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904) V. Vendrely; P. Ronchin; K. Le-Malicot; M. Minsat; C. Lemanski; X. Mirabel; A. Lievre; A. Darut-Jouve; C. de la Fouchardiere; G. Breysacher; D. Argo-Leignel; E. Thimonier; N. Magne; C. Belletier; C. Lepage; T. Aparicio 2021 |
|
|
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase II study with panitumumab (FFCD 0904). T. Aparicio; P. Ronchin; L. Bazire; K. Le Malicot; C. Lemanski; X. Mirabel; P.L. Etienne; A. Lievre; W. Cacheux; A. Darut-Jouve; C. de la Fouchardiere; G. Breysacher; D.Argo Leignel; A. Tessier; N. Magne; M. Ben Abdelghani; C. Lepage; V. Vendrely 2019 |
10.1200/JCO.2019.37.15_suppl.3570 |
|
ANTI-FUNGAL AND ANTI-TERMITE ACTIVITY OF EXTRACTIVES COMPOUNDS FROM THERMALLY MODIFIED ASH WOODS K. Condelier; M.F. Thevenon; R. Collet; P. Gerardin; S. Dumarcay 2020 |
10.4067/S0718-221X2020005000209 |
|
Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1 beta and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms S. Allain-Maillet; A. Bosseboeuf; N. Mennesson; M. Bostoen; L. Dufeu; E.Ho Choi; C. Cleyrat; O. Mansier; E. Lippert; Y. Le Bris; J.M. Gombert; F. Girodon; M. Pettazzoni; E. Bigot-Corbel; S. Hermouet 2020 |
10.3390/cancers12092446 |
|
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients M. Jachiet; M. Samson; V. Cottin; J.E. Kahn; G. Le Guenno; P. Bonniaud; H. Devilliers; L. Bouillet; A. Gondouin; F. Makhlouf; N. Meaux-Ruault; H. Gil; B. Bienvenu; A. Coste; M. Groh; V. Giraud; S. Dominique; B. Godeau; X. Puechal; C. Khouatra; M. Ruivard; C. Le Jeunne; L. Mouthon; L. Guillevin; B. Terrier; F.Vasculitis Grp 2016 |
10.1002/art.39663 |
|
Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis: data from 17 patients M. Jachiet; M. Samson; V. Cottin; J. Kahn; G. Le Guenno; C. Le Jeunne; L. Mouthon; L. Guillevin; B. Terrier 2016 |
10.1016/j.jid.2016.06.032 |
|
Anti-IgE Monoclonal Antibody in Refractory and/or Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Data from 17 Patients M. Jachiet; M. Samson; V. Cottin; J.E. Kahn; G. Le Guenno; P. Bonniaud; L. Bouillet; A. Gondouin; F. Makhlouf; N.Meaux Ruault; H. Gil; H. Devilliers; B. Bienvenu; A. Coste; V. Giraud; S. Dominique; B. Godeau; X. Puechal; C. Khouatra; M. Ruivard; C. Le Jeunne; L. Mouthon; L. Guillevin; B. Terrier 2015 |
|
|
Anti-IgE Monoclonal Antibody in Refractory and/or Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Data from 17 Patients M. Jachiet; M. Samson; V. Cottin; J.E. Kahn; G. Le Guenno; P. Bonniaud; L. Bouillet; A. Gondouin; F. Makhlouf; N.Meaux Ruault; H. Gil; H. Devilliers; B. Bienvenu; A. Coste; V. Giraud; S. Dominique; B. Godeau; X. Puechal; C. Khouatra; M. Ruivard; C. Le Jeunne; L. Mouthon; L. Guillevin; B. Terrier 2015 |
|
|
Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis D. Wendling; F. Verhoeven; C. Prati 2019 |
10.1080/14712598.2019.1554053 |
|
Anti-Infectious Pathogen Specificity of Purified Monoclonal Immunoglobulins from Patients with MGUS and Multiple Myeloma A. Bosseboeuf; D. Feron; J. Harb; C. Charlier; A. Tallet; F. Girodon; L. Garderet; C. Rossi; D. Caillot; V. Salle; P. Moreau; P. Weigel; J.C. Pages; E. Piver; E. Bigot-Corbel; S. Hermouet 2016 |
10.1182/blood.V128.22.4413.4413 |
|
Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis H.D. Jhundoo; T. Siefen; A. Liang; C. Schmidt; J. Lokhnauth; A. Beduneau; Y. Pellequer; C.Casper Larsen; A. Lamprecht 2020 |
10.3390/pharmaceutics12111038 |
|
Anti-inflammatory effect of grape (Vitis vinifera L.) seed extract through the downregulation of NF-kappa B and MAPK pathways in LPS-induced RAW264.7 macrophages H. Harbeoui; A. Hichami; A. Wannes; J. Lemput; S. Tounsi; N.A. Khan 2019 |
10.1016/j.sajb.2019.06.026 |